BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36575788)

  • 21. SENP1 inhibits ferroptosis and promotes head and neck squamous cell carcinoma by regulating ACSL4 protein stability via SUMO1.
    Xu X; Mao Y; Feng Z; Dai F; Gu T; Zheng J
    Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hypoxia increases chemotherapy resistance in nasopharyngeal carcinoma via inducing CDK6 deSUMOylation].
    Ren Q; Liu FT; Zhang CY; Li LL; Cheng RZ; Liu XZ; Liu Q; Zhou HF
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 54(7):524-528. PubMed ID: 31315360
    [No Abstract]   [Full Text] [Related]  

  • 23. Small ubiquitin-like modifier/sentrin-specific peptidase 1 associates with chemotherapy and is a risk factor for poor prognosis of non-small cell lung cancer.
    Liu K; Zhang J; Wang H
    J Clin Lab Anal; 2018 Nov; 32(9):e22611. PubMed ID: 30043429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noncovalent structure of SENP1 in complex with SUMO2.
    Ambaye ND
    Acta Crystallogr F Struct Biol Commun; 2019 May; 75(Pt 5):332-339. PubMed ID: 31045562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
    Yan ZY; Sun XC
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
    [No Abstract]   [Full Text] [Related]  

  • 26. SENP1 desensitizes hypoxic ovarian cancer cells to cisplatin by up-regulating HIF-1α.
    Ao Q; Su W; Guo S; Cai L; Huang L
    Sci Rep; 2015 Nov; 5():16396. PubMed ID: 26548925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SENP1 has an important role in lung development and influences the differentiation of alveolar type 2 cells.
    Wan XQ; Cai JY; Zhu Y; Wang QX; Zhu HT; Ju HM; Lu HY
    Int J Mol Med; 2019 Jan; 43(1):371-381. PubMed ID: 30387808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SENP1-mediated NEMO de-SUMOylation inhibits intermittent hypoxia induced inflammatory response of microglia in vitro.
    Yang T; Sun J; Wei B; Liu S
    J Cell Physiol; 2020 Apr; 235(4):3529-3538. PubMed ID: 31549402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Senp1 is essential for desumoylating Sumo1-modified proteins but dispensable for Sumo2 and Sumo3 deconjugation in the mouse embryo.
    Sharma P; Yamada S; Lualdi M; Dasso M; Kuehn MR
    Cell Rep; 2013 May; 3(5):1640-50. PubMed ID: 23684609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the desumoylation process of SENP1: a study combined MD simulations with QM/MM calculations on SENP1-SUMO1-RanGAP1.
    Shi T; Han Y; Li W; Zhao Y; Liu Y; Huang Z; Lu S; Zhang J
    J Chem Inf Model; 2013 Sep; 53(9):2360-8. PubMed ID: 23930863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SENP1 is a crucial promotor for hepatocellular carcinoma through deSUMOylation of UBE2T.
    Tao Y; Li R; Shen C; Li J; Zhang Q; Ma Z; Wang F; Wang Z
    Aging (Albany NY); 2020 Jan; 12(2):1563-1576. PubMed ID: 31969492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insights into the Allosteric Effect of SENP1 Q597A Mutation on the Hydrolytic Reaction of SUMO1 via an Integrated Computational Study.
    Ji M; Chai Z; Chen J; Li G; Li Q; Li M; Ding Y; Lu S; Ju G; Hou J
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Momordin Ic, a new natural SENP1 inhibitor, inhibits prostate cancer cell proliferation.
    Wu J; Lei H; Zhang J; Chen X; Tang C; Wang W; Xu H; Xiao W; Gu W; Wu Y
    Oncotarget; 2016 Sep; 7(37):58995-59005. PubMed ID: 27449295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cisplatin increases B-cell-lymphoma-2 expression via activation of protein kinase C and Akt2 in endometrial cancer cells.
    Rouette A; Parent S; Girouard J; Leblanc V; Asselin E
    Int J Cancer; 2012 Apr; 130(8):1755-67. PubMed ID: 21618512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SENP1 modulates microglia-mediated neuroinflammation toward intermittent hypoxia-induced cognitive decline through the de-SUMOylation of NEMO.
    Wang H; Yang T; Sun J; Zhang S; Liu S
    J Cell Mol Med; 2021 Jul; 25(14):6841-6854. PubMed ID: 34120412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Polymorphism of SUMO-Specific Cysteine Proteases - SENP1 and SENP2 in Breast Cancer.
    Mirecka A; Morawiec Z; Wozniak K
    Pathol Oncol Res; 2016 Oct; 22(4):817-23. PubMed ID: 27178176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer.
    Wei M; Huang X; Liao L; Tian Y; Zheng X
    Cancer Res; 2023 Sep; 83(17):2908-2923. PubMed ID: 37350666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging role of SENP1 in tumorigenesis and cancer therapy.
    Lin M; Zhang M; Yi B; Chen J; Wen S; Chen R; Chen T; Li Z
    Front Pharmacol; 2024; 15():1354323. PubMed ID: 38389923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SUMOylation of the ubiquitin ligase IDOL decreases LDL receptor levels and is reversed by SENP1.
    Wang JQ; Lin ZC; Li LL; Zhang SF; Li WH; Liu W; Song BL; Luo J
    J Biol Chem; 2021; 296():100032. PubMed ID: 33154164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MYB regulates the SUMO protease SENP1 and its novel interaction partner UXT, modulating MYB target genes and the SUMO landscape.
    Lemma RB; Ledsaak M; Fuglerud BM; Rodríguez-Castañeda F; Eskeland R; Gabrielsen OS
    J Biol Chem; 2023 Sep; 299(9):105062. PubMed ID: 37468105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.